Biotechnology, patients' rights, and the Moore case.
D000533:Altruism; D026686:Beneficence; D035843:Biomedical Research; D002140:California; D035881:Compensation and Redress; D016265:Conflict of Interest; D004274:DNA, Recombinant; D030881:Disclosure; D004467:Economics; D005249:Fees and Charges; D005610:Freedom; D005818:Genetic Engineering; D018594:Human Body; D006805:Human Experimentation; D006801:Humans; D007221:Industry; D007258:Informed Consent; D007603:Jurisprudence; D016365:Liability, Legal; D010067:Ownership; D010330:Patents as Topic; D010344:Patient Advocacy; D028701:Patient Rights; D026684:Personal Autonomy; D010817:Physician-Patient Relations; D010820:Physicians; D012106:Research; D012108:Research Personnel; D012306:Risk; D018570:Risk Assessment; D014019:Tissue Donors; D009927:Tissue and Organ Procurement; D014495:Universities
Biomedical and Behavioral Research; Health Care and Public Health; Legal Approach; Moore v. Regents of the University of California; Professional Patient Relationship